CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-11 | BAKER BROS. ADVISORS LP Director | Purchase · 2026 $0.0001 Prefunded Warrants | +126,394 | $12.06 | $1.5M | 126,394 |
| 2026-08-11 | BAKER BROS. ADVISORS LP Director | Purchase · 2026 $0.0001 Prefunded Warrants | +2,609,946 | $12.06 | $31.5M | 2,609,946 |
| 2026-04-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +44,500 | 44,500 | ||
| 2026-04-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +44,500 | 44,500 | ||
| 2025-03-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +64,000 | 64,000 | ||
| 2025-03-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +64,000 | 64,000 |
Page 1 of 1 · 6 trades